CPDA-1
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- CPDA-1
- Generic name
- ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE
- Manufacturer
- Fenwal, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- cf9f43a0-c750-4cf0-ac49-176ab2105aab
- SPL ID
- fd410caf-3513-4688-ae7e-0cae94a0c2d7
- Version
- 8
- Effective date
- 2021-12-02
- Source export date
- 2026-10-12
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:14:43
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | BN770420 | openfda.application_number | |
| brand name | CPDA-1 | openfda.brand_name | |
| generic name | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | openfda.generic_name | |
| manufacturer name | Fenwal, Inc. | openfda.manufacturer_name | |
| ndc | package | 0942-9398-02 | openfda.package_ndc |
| ndc | product | 0942-9398 | openfda.product_ndc |
| ndc11 | package | 00942939802 | derived:openfda.package_ndc |
| spl id | fd410caf-3513-4688-ae7e-0cae94a0c2d7 | id | |
| spl set id | cf9f43a0-c750-4cf0-ac49-176ab2105aab | set_id | |
| unii | JAC85A2161 | openfda.unii | |
| unii | XF417D3PSL | openfda.unii | |
| unii | B22547B95K | openfda.unii | |
| unii | LX22YL083G | openfda.unii | |
| unii | 593YOG76RN | openfda.unii |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.